The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127256261 12725626 1 I 20150309 20150410 20160908 20160908 EXP JP-PFIZER INC-2015132477 PFIZER 36.00 YR F Y 46.25000 KG 20160908 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127256261 12725626 1 PS SIROLIMUS. SIROLIMUS 1 Oral 2 MG, DAILY Y 21110 2 MG
127256261 12725626 2 C LASIX FUROSEMIDE 1 Oral UNK 0
127256261 12725626 3 C ALDACTONE-A SPIRONOLACTONE 1 Oral UNK 0
127256261 12725626 4 C VOLIBRIS AMBRISENTAN 1 Oral UNK 0
127256261 12725626 5 C INDERAL PROPRANOLOL HYDROCHLORIDE 1 Oral UNK 0
127256261 12725626 6 C GASCON DIMETHICONE 1 Oral UNK 0
127256261 12725626 7 C ADCIRCA TADALAFIL 1 Oral 1 DF, UNK 0 1 DF
127256261 12725626 8 C ADCIRCA TADALAFIL 1 Oral 2 DF, UNK 0 2 DF
127256261 12725626 9 C ASPARA POTASSIUM POTASSIUM ASPARTATE 1 Oral UNK 0
127256261 12725626 10 C FAMOTIDINE. FAMOTIDINE 1 Oral UNK 0
127256261 12725626 11 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral UNK 0
127256261 12725626 12 C IMURAN AZATHIOPRINE 1 Oral UNK 0
127256261 12725626 13 C ASACOL MESALAMINE 1 Oral UNK 0
127256261 12725626 14 C LAC-B BIFIDOBACTERIUM SPP. 1 Oral UNK 0
127256261 12725626 15 C MYSLEE ZOLPIDEM TARTRATE 1 Oral UNK, AS NEEDED 0
127256261 12725626 16 C ACTONEL RISEDRONATE SODIUM 1 Oral UNK 0
127256261 12725626 17 C PENTASA MESALAMINE 1 Parenteral UNK 0
127256261 12725626 18 C HEPARIN CA 2 Intravenous (not otherwise specified) UNK 0 INJECTION
127256261 12725626 19 C RECOMODULIN THROMBOMODULIN ALFA 1 UNK 0 INJECTION
127256261 12725626 20 C AMBISOME AMPHOTERICIN B 1 Intravenous (not otherwise specified) UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127256261 12725626 1 Lymphangioleiomyomatosis
127256261 12725626 5 Lymphangioleiomyomatosis
127256261 12725626 15 Insomnia
127256261 12725626 20 Pneumonia

Outcome of event

Event ID CASEID OUTC COD
127256261 12725626 HO
127256261 12725626 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127256261 12725626 Cardiac failure
127256261 12725626 Hypokalaemia
127256261 12725626 Interstitial lung disease
127256261 12725626 Platelet count decreased
127256261 12725626 Renal impairment
127256261 12725626 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127256261 12725626 1 20150304 20150327 0
127256261 12725626 8 20150423 0
127256261 12725626 10 20150416 0
127256261 12725626 11 20150410 0
127256261 12725626 16 20150401 0
127256261 12725626 19 20150319 20150325 0
127256261 12725626 20 20150326 20150507 0